A
$ Value
$0
Shares
165,000
Price
$0
Filed
Feb 10
Insider
Name
Wilson Mark Andrew
Title
Chief Legal Officer
CIK
0001808356
Roles
Officer
Transaction Details
Transaction Date
2026-02-06
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
165,000
Footnotes
25% of the shares underlying this option will vest on January 5, 2027, and the remaining 75% of the shares underlying this option will vest in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Filing Info
Wilson Mark Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-06 | SEPN | A | $0 |
| 2025-11-25 | NKTR | ▼ | $34K |
| 2025-11-21 | NKTR | A | $0 |
| 2025-11-21 | NKTR | A | $0 |
| 2025-08-19 | NKTR | ▼ | $18K |
| 2025-08-19 | NKTR | A | $0 |
| 2025-05-19 | NKTR | ▼ | $7K |
Other Insiders at SEPN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Labrucherie Gil M
Chief Financial Officer
|
— | — | 2026-02-06 |
|
Bhatt Elizabeth
President and COO
|
— | $213K | 2026-04-15 |
|
Kim Jae B.
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Long Daniel D.
SVP, Drug Discovery
|
— | — | 2026-02-06 |
|
Klein Uwe
SVP, Biological Sciences
|
— | — | 2026-02-06 |
|
Shaikhly Samira
Chief People Officer
|
— | — | 2026-02-06 |
|
Finer Jeffrey
Chief Executive Officer
|
— | — | 2026-02-06 |